Proteomics Market Size At Around US$ 74.8 Bn In 2030

The proteomics market would grow at a CAGR of 12.41% over the predicted time frame. The market is expected to increase in value from US$ 29.34 Bn in 2022 to US$ 74.8  Bn in 2030.

Key Takeaways:

• North America region accounted for 46.2% of the total revenue share in 2021.
• By products, the consumables and the reagents segment accounted for 71.5% of revenue share in 20 21.
• By technology, the spectroscopy segment has captured 47.6% revenue share in 2021.
• By application, the clinical diagnostics segment has held a revenue share of over 51.8% in 2021.

The on proteomics Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2306

A recent report provides crucial insights along with application based and forecast information in the Global Proteomics Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Proteomics market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Proteomics market are included as given below:

Proteomics Market Key Players

• Thermo Fisher scientific
• Alumna incorporated
• Creative proteomics
• GE healthcare
• Integrated proteomics applications

Market Segments

By Product

• Instruments
• Consumables and reagents
  • Immunoassay Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Protein Microarray Reagents
  • X-Ray Crystallography Reagents
  • Electrophoresis Reagents
  • Protein Fractionation Reagents
  • Services

By Application

• Drug Discovery
  • Target Discovery
  • Lead Identification
  • Lead Optimization
  • Preclinical Studies
• Clinical Diagnostics
  • Cancer
  • Immune Diseases
  • Infectious Diseases
  • Neurological Disorders
  • Diabetes
  • Cardiovascular Diseases
  • Other Clinical Diagnostic Applications
• Others

By Technology

• Spectroscopy
  • NMR Spectroscopy
  • CD Spectroscopy
  • Mass Spectroscopy
• Microarray instruments
• Chromatography
  • HPLC
  • Ion Chromatography
  • Affinity Chromatography
  • Supercritical Fluid Chromatography
• X-ray crystallography
• Protein Microarrays
  • Biochips
    • Lab-on-Chips
    • Protein Chips
  • Microarray Instruments
    • Integrated Systems
    • Microarray Scanners
    • Arrayers
• Electrophoresis
  • Gel Electrophoresis
  • Capillary Electrophoresis
• Protein fractionation system
• Surface plasma resonance systems

By Software & Service

• Core Proteomics Services
  • Protein Identification Services
  • Protein Characterization Services
  • Quantitative Proteomic Services
  • Protein Purification Services
  • Protein Sequencing Services
  • Custom Assay Services
• Bioinformatics Software & Services
  • Bioinformatics Software
  • Bioinformatics Tools
  • Bioinformatics Databases

By End User

• Hospitals
• Clinical Laboratories
• Pharmaceutical Companies
• Academic Research Laboratories
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Report Objectives

• To define, describe, and forecast the global proteomics market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the proteomics market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Proteomics Market 

5.1. COVID-19 Landscape: Proteomics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Proteomics Market, By Product

8.1. Proteomics Market, by Product, 2022-2030

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Consumables and reagents

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Proteomics Market, By Application

9.1. Proteomics Market, by Application, 2022-2030

9.1.1. Drug Discovery

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Clinical Diagnostics

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Proteomics Market, By Technology 

10.1. Proteomics Market, by Technology, 2022-2030

10.1.1. Spectroscopy

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Microarray instruments

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Chromatography

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. X-ray crystallography

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Protein Microarrays

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Electrophoresis

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Protein fractionation system

10.1.7.1. Market Revenue and Forecast (2017-2030)

10.1.8. Surface plasma resonance systems

10.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Proteomics Market, By Software & Service

11.1. Proteomics Market, by Software & Service, 2022-2030

11.1.1. Core Proteomics Services

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Bioinformatics Software & Services

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Proteomics Market, By End User

12.1. Proteomics Market, by End User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Clinical Laboratories

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Pharmaceutical Companies

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Academic Research Laboratories

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Proteomics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.4. Market Revenue and Forecast, by Software & Service (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.7. Market Revenue and Forecast, by Software & Service (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.10. Market Revenue and Forecast, by Software & Service (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Software & Service (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Thermo Fisher scientific

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Alumna incorporated

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Creative proteomics

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. GE healthcare

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Integrated proteomics applications

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com